Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02665715
Other study ID # DK-REAKTIV-15
Secondary ID
Status Completed
Phase N/A
First received January 25, 2016
Last updated July 20, 2016
Start date August 2015
Est. completion date June 2016

Study information

Verified date July 2016
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection AgencyDenmark: The National Committee on Health Research Ethics
Study type Interventional

Clinical Trial Summary

Roux-en-Y gastric bypass (RYGB) accelerates nutrient delivery to the small intestine causing higher peak blood glucose concentration early after meal intake. In the late postprandial period (1 1⁄2-2 h) nadir blood glucose level is lower compared with before operation. In some patients, overt postprandial hypoglycaemia develops, and is typically reported as a complication 1-5 years postoperatively, when maximal weight loss has been obtained. The pathophysiology of postprandial hypoglycaemia involves inappropriate hyper-secretion of insulin associated with exaggerated secretion of the gut hormone glucagon-like peptide-1 (GLP-1) leading to a mismatch between glucose absorption rate, insulin secretion and whole body glucose disposal. We hypothesize that lowering carbohydrate content of meals reduces postprandial glucose excursions whereby GLP-1 and insulin secretion is reduced and reactive hypoglycemia prevented.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria:

- RYGB operated patients more than 12 month after operation

- Stable in weight for at least 3 months (+/- 3 kg)

- Plasma glucose below 3.4 mmol/L after screening with test meal (Fresubin drink) or with continuous glucose monitoring

Exclusion Criteria:

- Fasting plasma glucose concentration > 7mmol/L

- Critical illness

- Hgb < 6.5 mM

- Pregnancy or breastfeeding

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Low carbohydrate meals
Meal macronutritional energy composition: Carbohydrate 30% Protein 30% Fat 40%
Standard carbohydrate meals
Meal macronutritional energy composition: Carbohydrate 55% Protein 15% Fat 30%

Locations

Country Name City State
Denmark Endocrinology Research Center, Hvidovre University Hospital Hvidovre Copenhagen

Sponsors (2)

Lead Sponsor Collaborator
Amirsalar Samkani Hvidovre University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Nadir plasma glucose Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Peak plasma glucose Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Time to nadir glucose Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Time to peak glucose Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Postprandial incremental glucose area Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Postprandial decremental glucose area Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Postprandial incremental insulin area Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Postprandial incremental GLP-1 area Between low carbohydrate meal and standard meal. 0-240 min, 240-480 min No
Secondary Time below basline glucose concentrations Between low carbohydrate meal and standard meal. 0-480 min No
Secondary Glycemic excursions Between low carbohydrate meal and standard meal. 0-480 min No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02374632 - Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass Phase 4
Active, not recruiting NCT02372526 - The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation N/A